Valuation: Amedica Corporation

Market Cap 7.04M 6.09M 5.69M 5.22M 9.81M 670M 9.96M 66.71M 26.15M 336M 26.43M 25.86M 1.11B P/E 2026 *
-0.76x
P/E 2027 * -1.14x
Enterprise Value 7.04M 6.09M 5.69M 5.22M 9.81M 670M 9.96M 66.71M 26.15M 336M 26.43M 25.86M 1.11B EV / Sales 2026 *
3.06x
EV / Sales 2027 * 1.34x
Free-Float
75.59%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 30/11/2007
President - 15/03/2026
Director of Finance/CFO 41 03/09/2025
Director TitleAgeSince
Director/Board Member 63 30/11/2007
Director/Board Member 63 02/04/2025
Director/Board Member 72 04/11/2012
Change 5-day change 1-year change 3-year change Capi.($)
-7.92%-7.29% - - 7.04M
+0.47%-2.59%-9.58%+19.50% 129B
+1.37%-6.31%-16.79%-1.20% 12.43B
+5.28%+6.82%+103.44%+141.90% 10.08B
+2.59%-2.36%-42.76%-68.89% 4.58B
+2.93%+0.77%-14.62%+40.45% 2.62B
+2.16%+20.27%-23.31%-78.30% 1.7B
+2.82%+1.41%-14.77%-17.47% 1.64B
+2.16%+0.31%-30.10%-31.98% 1.63B
Average +1.32%+1.24%-6.06%+0.50% 20.51B
Weighted average by Cap. +0.99%-2.68%-4.59%+21.42%

Financials

2026 *2027 *
Net sales 2.3M 1.99M 1.86M 1.71M 3.21M 219M 3.26M 21.83M 8.56M 110M 8.65M 8.46M 363M 5.27M 4.56M 4.25M 3.91M 7.34M 501M 7.45M 49.91M 19.56M 251M 19.78M 19.35M 831M
Net income -12.38M -10.71M -10M -9.18M -17.25M -1.18B -17.52M -117M -45.98M -590M -46.48M -45.46M -1.95B -11.38M -9.84M -9.19M -8.43M -15.85M -1.08B -16.1M -108M -42.26M -543M -42.71M -41.79M -1.79B
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-